Low Volatility Alert VIX -7.4%

ALT $1.88

0.05 (2.7%)


ALT Profile

Health Care
Biotech & Pharma
30 Million
Altimmune Inc is a United States-based clinical stage immunotherapeutic biotechnology company. It is involved in the business of developing products that engage, stimulate and improve immune responses for the prevention and treatment of diseases. The firm's product candidates include NasoVAX, HepTcell, SparVax-L, NasoShield, and Oncosyn. It also develops platform technologies such as RespirVec and Densigen. The company generates its revenue from cost plus fee contracts and fixed-price contracts.

ALT Earnings

Earnings Per Share (EPS)
Price To Earnings Ratio (P/E)
1st Quarter Earnings Report
for Jan, Feb & Mar

Wed, May 15, 2019 (205 days ago)
Since Earnings Report -28.5%
2nd Quarter Earnings Report
for Apr, May & Jun

Wed, Aug 14, 2019 (114 days ago)
Since Earnings Report -11.3%

ALT Dividend

Annual Dividend Yield
Annual Dividend Rate
Ex-Dividend Date
Fri, Dec 21, 2018 (350 days ago)
Dividend Pay Date
Mon, Dec 31, 2018
Dividend Payments
99 Payments (Biannual)

ALT Charts

All Time High $2,100.00 Wed, Aug 8, 2007

Symbol Price Day YTD
ALT $1.88 2.7% -27.7%

Westpac Banking, Banco Santander - Chile ADS, Banco De Chile Banco De Chile ADS, National Western Life Group Inc & Tortoise Energy Infrastructure Corp..

General Motors, Ford Motor Co, FIAT CHRYSLER AUTOMOBILES N V, Harley-Davidson Inc & Adient PLC.

Symbol Surfing

How can we make Symbol Surfing better?



©2019 Symbol Surfing All Rights Reserved.

Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Cookies Policy Terms Of Service Privacy Policy